Methotrexate for Hidradenitis Suppurativa | myHSteam

Connect with others who understand.

sign up Log in
About myHSteam
Powered By

Methotrexate is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat severe cases of psoriasis, rheumatoid arthritis, and some types of cancer. Methotrexate is sometimes prescribed to treat hidradenitis suppurativa (HS). In cases of HS, methotrexate is often prescribed in combination with another medication such as Humira. Methotrexate is sold under brand names including Rheumatrex and Trexall.

Methotrexate is an immunomodulator, or drug that modifies the immune system. Methotrexate is a type of disease-modifying antirheumatic drug (DMARD). Methotrexate is believed to suppress the immune system in several ways, reducing the activity of T cells, B cells, interleukins, and enzymes that play a role in autoimmune attacks.

How do I take it?
Methotrexate is generally prescribed to be taken once or twice each week.

Methotrexate may be taken orally or by intramuscular or intravenous injection.

Side effects
The FDA-approved label for methotrexate lists common side effects including nausea, vomiting, loss of appetite, and temporary hair loss.

Rare but serious side effects listed for Methotrexate include infections, birth defects, seizures, and damage to liver, lungs, or kidneys.

For more details about this treatment, visit:

Methotrexate —

Hidradenitis Suppurativa: A Review With an Emphasis on Treatment — Consultant 360

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in